(Q38034060)

English

What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research

scientific article published on 12 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Alzheimer's disease

0 references

4

object named as

Peter Riederer

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Melita Salkovic-Petrisic

1

object named as

Melita Salkovic-Petrisic

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

2

object named as

Ana Knezovic

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

author name string

Siegfried Hoyer

3

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

publication date

12 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Journal of Neural Transmission

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

120

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

233-252

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Study of neuroprotection of donepezil, a therapy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Behavioral and biochemical effects of an ICV injection of streptozotocin in old Lewis rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Oxidative stress in Alzheimer disease: a possibility for prevention

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Extended results of the Alzheimer's disease anti-inflammatory prevention trial

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Iron: the Redox-active center of oxidative stress in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

The role of iron as a mediator of oxidative stress in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Brain-derived neurotrophic factor is reduced in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Potential of ezetimibe in memory deficits associated with dementia of Alzheimer's type in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Memory restorative role of statins in experimental dementia: an evidence of their cholesterol dependent and independent actions

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Developing β-secretase inhibitors for treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Oxidative stress: free radical production in neural degeneration.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Changes in hippocampal synapses and learning-memory abilities in a streptozotocin-treated rat model and intervention by using fasudil hydrochloride.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Alzheimer disease--no target for statin treatment. A mini review

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761).

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT).

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effects of treadmill exercise on memory and c-Fos expression in the hippocampus of the rats with intracerebroventricular injection of streptozotocin

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Vitamin E in neurodegenerative disorders: Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effects of Estradiol (-17beta) on learning, memory and cerebral energy metabolism in male rats after intracerebroventricular administration of streptozotocin

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

(Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Regulation of APP cleavage by alpha-, beta- and gamma-secretases

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Organoselenium improves memory decline in mice: involvement of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Neuroprotector effect of p,p'-methoxyl-diphenyl diselenide in a model of sporadic dementia of Alzheimer's type in mice: contribution of antioxidant mechanism.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Spatial discrimination learning and choline acetyltransferase activity in streptozotocin-treated rats: effects of chronic treatment with acetyl-L-carnitine.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Wheel-running in a transgenic mouse model of Alzheimer's disease: protection or symptom?

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

New polyphenols active on beta-amyloid aggregation

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Treating transgenic Alzheimer mice with a β-secretase inhibitor, what have we learned?

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Idebenone treatment fails to slow cognitive decline in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Therapeutic potential of resveratrol in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Causes of oxidative stress in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0877-9

21 January 2018

Experimental pharmacology of Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Chinese herbal medicine Yinsiwei compound on spatial learning and memory ability and the ultrastructure of hippocampal neurons in a rat model of sporadic Alzheimer disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physical exercise exacerbates memory deficits induced by intracerebroventricular STZ but improves insulin regulation of H₂O₂ production in mice synaptosomes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

M30, a brain permeable multitarget neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer's disease and the amyloid cascade hypothesis: a critical review

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ginkgo biloba for cognitive impairment and dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment with lithium alleviates memory deficits and reduces amyloid-β production in an aged Alzheimer's disease transgenic mouse model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00702-012-0877-9

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38034060&oldid=2201193742"